shihou.hayashi personal page - To The Moon

shihou.hayashi

No personal profile

7Follow

3Followers

0Topic

0Badge

10-09

$Palantir Technologies Inc.(PLTR)$ Best investment of my life

02-15

$Palantir Technologies Inc.(PLTR)$ LFG

07-16

Every time we have nice things some dumb fucking analyst comes and f it up

Palantir Slips 3% Following Ratings Downgrade from Mizuho

07-05

$(PLTR)$ oh my god! Let's go!

08-06

$Palantir Technologies Inc.(PLTR)$ Solid earning report! Congrats to all the shareholders! Keep believing in Karp!

07-09

$Palantir Technologies Inc.(PLTR)$ In Karp we trust

07-18

$Palantir Technologies Inc.(PLTR)$ new 52w high again! Stonk!

02-28

$Palantir Technologies Inc.(PLTR)$ LFG!!

10-03

$Palantir Technologies Inc.(PLTR)$ Milestone HIT! 🚀🚀🚀 💎💎💎

09-19

$Palantir Technologies Inc.(PLTR)$

08-06

$Palantir Technologies Inc.(PLTR)$ In Karp we trust

05-07

$Palantir Technologies Inc.(PLTR)$

2022-07-27

Good

Is Palantir Stock A Buy As It Nears All-Time Lows?

08-10

$Palantir Technologies Inc.(PLTR)$

08-10

$Palantir Technologies Inc.(PLTR)$ We finally hit the magic number $30! LFG!

07-19

Thanks for the feature. Let’s hope palantir will go higher 🚀🚀🚀

07-11

$Palantir Technologies Inc.(PLTR)$ BULLISH!

06-19

$Palantir Technologies Inc.(PLTR)$

03-08

$Palantir Technologies Inc.(PLTR)$

2021-12-21

Gogogo

Palantir and Dewpoint Therapeutics Announce Strategic Partnership

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4099388038790400","uuid":"4099388038790400","gmtCreate":1636286378427,"gmtModify":1707541461470,"name":"shihou.hayashi","pinyin":"shihouhayashishihouhayashi","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":"https://static.tigerbbs.com/ae1f49570794979e009a5efdeb6f4789","hatId":"ca_profile_frame_ugQHMi","hatName":"LV7 头像框","vip":1,"status":2,"fanSize":3,"headSize":7,"tweetSize":20,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.08.04","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.25","exceedPercentage":"60.83%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.08","exceedPercentage":"60.84%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.08","exceedPercentage":"60.12%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},"individualDisplayBadges":null,"crmLevel":8,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":358052543648136,"gmtCreate":1728451957883,"gmtModify":1728473997376,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> Best investment of my life","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> Best investment of my life","text":"$Palantir Technologies Inc.(PLTR)$ Best investment of my life","images":[{"img":"https://community-static.tradeup.com/news/387a496b3a6d3e92da13946f324ae091","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/358052543648136","isVote":1,"tweetType":1,"viewCount":919,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":356165444690304,"gmtCreate":1727963929454,"gmtModify":1727963991459,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> Milestone HIT! 🚀🚀🚀 💎💎💎","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> Milestone HIT! 🚀🚀🚀 💎💎💎","text":"$Palantir Technologies Inc.(PLTR)$ Milestone HIT! 🚀🚀🚀 💎💎💎","images":[{"img":"https://community-static.tradeup.com/news/6dc62068ca3941bd829a78bd1ea04ecd","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/356165444690304","isVote":1,"tweetType":1,"viewCount":138,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":351097361915912,"gmtCreate":1726739607578,"gmtModify":1726739610581,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$","images":[{"img":"https://community-static.tradeup.com/news/73f54711475004d336ec2234769054ec","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/351097361915912","isVote":1,"tweetType":1,"viewCount":39,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":336643815297128,"gmtCreate":1723224518881,"gmtModify":1723224522999,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$","images":[{"img":"https://community-static.tradeup.com/news/e69bf423a2e711db9f467dc6fe70fe4f","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/336643815297128","isVote":1,"tweetType":1,"viewCount":107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":336631816429952,"gmtCreate":1723223964592,"gmtModify":1723223969043,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> We finally hit the magic number $30! LFG!","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> We finally hit the magic number $30! LFG!","text":"$Palantir Technologies Inc.(PLTR)$ We finally hit the magic number $30! LFG!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/336631816429952","isVote":1,"tweetType":1,"viewCount":81,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":335472655327440,"gmtCreate":1722932347233,"gmtModify":1722932350590,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> In Karp we trust","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> In Karp we trust","text":"$Palantir Technologies Inc.(PLTR)$ In Karp we trust","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/335472655327440","isVote":1,"tweetType":1,"viewCount":198,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":335302235058312,"gmtCreate":1722890861188,"gmtModify":1722890866689,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> Solid earning report! Congrats to all the shareholders! Keep believing in Karp!","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> Solid earning report! Congrats to all the shareholders! Keep believing in Karp!","text":"$Palantir Technologies Inc.(PLTR)$ Solid earning report! Congrats to all the shareholders! Keep believing in Karp!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/335302235058312","isVote":1,"tweetType":1,"viewCount":198,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329244912992416,"gmtCreate":1721387710194,"gmtModify":1721387714602,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"Thanks for the feature. Let’s hope palantir will go higher 🚀🚀🚀","listText":"Thanks for the feature. Let’s hope palantir will go higher 🚀🚀🚀","text":"Thanks for the feature. Let’s hope palantir will go higher 🚀🚀🚀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/329244912992416","isVote":1,"tweetType":1,"viewCount":260,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":328854834770136,"gmtCreate":1721312042407,"gmtModify":1721382115249,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> new 52w high again! Stonk!","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> new 52w high again! Stonk!","text":"$Palantir Technologies Inc.(PLTR)$ new 52w high again! Stonk!","images":[{"img":"https://community-static.tradeup.com/news/7f5d05558b3629c234c28e343c445444","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/328854834770136","isVote":1,"tweetType":1,"viewCount":268,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":328117935337528,"gmtCreate":1721136977959,"gmtModify":1721137026216,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"Every time we have nice things some dumb fucking analyst comes and f&nbsp;it up","listText":"Every time we have nice things some dumb fucking analyst comes and f&nbsp;it up","text":"Every time we have nice things some dumb fucking analyst comes and f it up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/328117935337528","repostId":"1162176667","repostType":2,"repost":{"id":"1162176667","pubTimestamp":1721136900,"share":"https://ttm.financial/m/news/1162176667?lang=&edition=fundamental","pubTime":"2024-07-16 21:35","market":"us","language":"en","title":"Palantir Slips 3% Following Ratings Downgrade from Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=1162176667","media":"Seeking Alpha","summary":"Palantir Technologies slipped nearly 3% in morning trading Tuesday after being downgraded to Underperform from Neutral by Mizuho Securities.Although Palantir has performed well in recent quarters, Miz","content":"<html><head></head><body><p>Palantir Technologies slipped nearly 3% in morning trading Tuesday after being downgraded to Underperform from Neutral by Mizuho Securities.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/f69bfd5e8314b7d2b924705c598f1307\" tg-width=\"874\" tg-height=\"622\"/></p><p style=\"text-align: left;\">Although Palantir has performed well in recent quarters, Mizuho analysts doubt whether the big data analytics software firm can maintain these results.</p><p style=\"text-align: left;\">&#34;But primarily, following the material 67% rise in the shares YTD, we find it increasingly difficult to justify PLTR&#39;s high multiple (21x CY25E revenue) that, in our view, likely already discounts significant acceleration versus our consensus expectations for 20-21% revenue growth,&#34; said Mizuho analysts led by Gregg Moskowitz, in a note.</p><p style=\"text-align: left;\">However, Mizuho slightly increased the price target on the Denver-based firm to $22 from $21.</p><p style=\"text-align: left;\">&#34;There are some exciting aspects of the PLTR story (megadeals, AIP), although this is offset by a lack of transparency and a likelihood of lumpy results going forward, in our view,&#34; Moskowitz added. &#34;Net, we have limited confidence in the company&#39;s ability to deliver consistently strong results and accelerating growth, which is needed to justify the premium valuation.&#34;</p><p style=\"text-align: left;\">Palantir has a Hold rating from Seeking Alpha analysts, Wall Street analysts and Seeking Alpha&#39;s Quant system, which routinely beats the market.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir Slips 3% Following Ratings Downgrade from Mizuho</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir Slips 3% Following Ratings Downgrade from Mizuho\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-16 21:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4124573-palantir-slips-pre-market-following-ratings-downgrade-from-mizuho><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Palantir Technologies slipped nearly 3% in morning trading Tuesday after being downgraded to Underperform from Neutral by Mizuho Securities.Although Palantir has performed well in recent quarters, ...</p>\n\n<a href=\"https://seekingalpha.com/news/4124573-palantir-slips-pre-market-following-ratings-downgrade-from-mizuho\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://seekingalpha.com/news/4124573-palantir-slips-pre-market-following-ratings-downgrade-from-mizuho","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1162176667","content_text":"Palantir Technologies slipped nearly 3% in morning trading Tuesday after being downgraded to Underperform from Neutral by Mizuho Securities.Although Palantir has performed well in recent quarters, Mizuho analysts doubt whether the big data analytics software firm can maintain these results.\"But primarily, following the material 67% rise in the shares YTD, we find it increasingly difficult to justify PLTR's high multiple (21x CY25E revenue) that, in our view, likely already discounts significant acceleration versus our consensus expectations for 20-21% revenue growth,\" said Mizuho analysts led by Gregg Moskowitz, in a note.However, Mizuho slightly increased the price target on the Denver-based firm to $22 from $21.\"There are some exciting aspects of the PLTR story (megadeals, AIP), although this is offset by a lack of transparency and a likelihood of lumpy results going forward, in our view,\" Moskowitz added. \"Net, we have limited confidence in the company's ability to deliver consistently strong results and accelerating growth, which is needed to justify the premium valuation.\"Palantir has a Hold rating from Seeking Alpha analysts, Wall Street analysts and Seeking Alpha's Quant system, which routinely beats the market.","news_type":1},"isVote":1,"tweetType":1,"viewCount":230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":326087482687560,"gmtCreate":1720635250261,"gmtModify":1720635306345,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> BULLISH!","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> BULLISH!","text":"$Palantir Technologies Inc.(PLTR)$ BULLISH!","images":[{"img":"https://community-static.tradeup.com/news/7f9c9b913d6a690e917ed62c31d3fde3","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/326087482687560","isVote":1,"tweetType":1,"viewCount":354,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":325664432181320,"gmtCreate":1720531966447,"gmtModify":1720532011342,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> In Karp we trust&nbsp;","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> In Karp we trust&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$ In Karp we trust","images":[{"img":"https://community-static.tradeup.com/news/a6f823ea775ca5dab2297475761c2a69","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325664432181320","isVote":1,"tweetType":1,"viewCount":410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":324236008308760,"gmtCreate":1720188385426,"gmtModify":1720188389878,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> oh my god! Let's go!","listText":"<a href=\"https://ttm.financial/S/PLTR\">$(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> oh my god! Let's go!","text":"$(PLTR)$ oh my god! Let's go!","images":[{"img":"https://community-static.tradeup.com/news/9fb9e88b1b58e5c7f970910f728b2512","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/324236008308760","isVote":1,"tweetType":1,"viewCount":410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":318289363521656,"gmtCreate":1718734666175,"gmtModify":1718734669565,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$","images":[{"img":"https://community-static.tradeup.com/news/08f6fcaed0586b3978a2c94e45753b73","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/318289363521656","isVote":1,"tweetType":1,"viewCount":210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":303305394200792,"gmtCreate":1715069508611,"gmtModify":1715069510947,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/303305394200792","isVote":1,"tweetType":1,"viewCount":494,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":282214718771320,"gmtCreate":1709908380804,"gmtModify":1709908384747,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$","images":[{"img":"https://community-static.tradeup.com/news/db1129be90521fe68e446a5d5ab97a4d","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/282214718771320","isVote":1,"tweetType":1,"viewCount":255,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":278953580851360,"gmtCreate":1709125514055,"gmtModify":1709127904834,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> LFG!!","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> LFG!!","text":"$Palantir Technologies Inc.(PLTR)$ LFG!!","images":[{"img":"https://community-static.tradeup.com/news/7fc81ab794fd2a52506d7364d1bdb4bc","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/278953580851360","isVote":1,"tweetType":1,"viewCount":245,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":273985532768496,"gmtCreate":1707928970141,"gmtModify":1707958195611,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a> LFG","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a> LFG","text":"$Palantir Technologies Inc.(PLTR)$ LFG","images":[{"img":"https://community-static.tradeup.com/news/5f067879f39aee6fa118f9ac26ac3447","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/273985532768496","isVote":1,"tweetType":1,"viewCount":375,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9909437020,"gmtCreate":1658901740860,"gmtModify":1676536226773,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9909437020","repostId":"2254256508","repostType":2,"repost":{"id":"2254256508","pubTimestamp":1658889304,"share":"https://ttm.financial/m/news/2254256508?lang=&edition=fundamental","pubTime":"2022-07-27 10:35","market":"us","language":"en","title":"Is Palantir Stock A Buy As It Nears All-Time Lows?","url":"https://stock-news.laohu8.com/highlight/detail?id=2254256508","media":"seekingalpha","summary":"SummaryPalantir's stock price has been under $10 for most of the May-July period, and it is currentl","content":"<html><head></head><body><p><b>Summary</b></p><ul><li>Palantir&#39;s stock price has been under $10 for most of the May-July period, and it is currently trading at one-third of its 52-week peak.</li><li>PLTR recorded an all-time low share price of $6.44 during intra-day trading on May 12, 2022, as the company&#39;s Q2 2022 guidance released on May 9, 2022 disappointed the market.</li><li>Palantir is a Buy now, because its 2H 2022 revenue should beat market expectations, and rising geopolitical tensions are a key driver of PLTR&#39;s medium-to-long term growth.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/23d0f121f38325521c0b8ebbb42b26b3\" tg-width=\"750\" tg-height=\"500\" referrerpolicy=\"no-referrer\"/><span>Michael Vi</span></p><p><b>Elevator Pitch</b></p><p><a href=\"https://laohu8.com/S/PLTR\">Palantir Technologies Inc.</a> (NYSE:PLTR) is rated as a Buy.</p><p>I did a comparison of PLTR with <a href=\"https://laohu8.com/S/SNOW\">Snowflake</a> Inc. (SNOW) in my earlier article published on April 8, 2022. In this recent update, I come to the conclusion that Palantir is a Buy now. PLTR is currently trading below $10 for the past three months or so, which means that the company&#39;s shares are back to where they were in the early days of its listing. This indicates that expectations for the company are low considering where its share price is, and Palantir is well-positioned to surprise the market with better-than-expected revenue growth in Q3 2022 and Q4 2022. More importantly, geopolitical tensions and conflicts are expected to drive an increase in the amount of money that governments around the world spend on defense, and Palantir is already a beneficiary as evidenced by recent contract wins.</p><p>Why Is Palantir Stock Near All-Time Lows?</p><p>Palantir debuted on the New York Stock Exchange on September 30, 2020 with its shares closing at $9.50 at the end of the trading day. PLTR&#39;s last done share price was $9.84 as of July 22, 2022, and the company&#39;s shares have been mostly trading below the $10 mark since early-May 2022, a sight last seen in late-2020.</p><p><b>PLTR&#39;s Share Price Chart Since Listing</b></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/eaf8580ab0adcab20086c9a2fbd22934\" tg-width=\"640\" tg-height=\"227\" referrerpolicy=\"no-referrer\"/><span>Seeking Alpha</span></p><p>Palantir set a new historical trough stock price of $6.44 during the May 12, 2022 trading day. Even though, the company&#39;s shares have risen from the lows, PLTR&#39;s closing price as of July 22 is still only a third of its 52-week high share price of $29.29.</p><p>It isn&#39;t a big surprise that PLTR&#39;s shares are trading at such lows. The market is expecting Palantir to deliver more modest top line expansion while taking more time to generate positive GAAP earnings in the current weak economic environment. The sell-side&#39;s consensus financial forecasts obtained from <i>S&amp;P Capital IQ</i> suggest that Palantir&#39;s revenue growth will moderate from above +40% for both fiscal 2020 and 2021 to below +30% for the FY 2022-2024 period. At the same time, PLTR is projected to stay loss-making on a GAAP basis in FY 2022 and FY 2023 at the very least.</p><p>In uncertain times like these, investors tend to favor profitable companies boasting predictable (albeit relatively lower) sales growth. This also means that companies like PLTR which are still unprofitable on a GAAP basis and are witnessing revenue growth deceleration will be penalized by the market. In that respect, Palantir&#39;s consensus forward next twelve months&#39; Enterprise Value-to-Revenue multiple has compressed from as high as 50 times in early- 2021 to under 10 times in the last three months as per <i>S&amp;P Capital IQ</i>.</p><p><b>PLTR Stock Key Metrics</b></p><p>PLTR&#39;s below-expectations 2Q 2022 management guidance revealed as part of the company&#39;s Q1 2022 financial results released on May 9, 2022 was the key factor that led to Palantir&#39;s shares falling to a historical low on May 12, 2022.</p><p>Palantir guided for the company to achieve a top line of $470 million and a non-GAAP adjusted operating profit margin of 20% for the second quarter of fiscal 2022. This implies that PLTR&#39;s revenue growth is forecasted to slow from +31% YoY in Q1 2022 to 25% YoY in Q2 2022, while its non-GAAP operating margin is estimated to contract from 26% to 20% over the same period.</p><p>Moreover, PLTR&#39;s guided Q2 2022 revenue and operating profit margin were -4% and -6.8 percentage points below the market&#39;s consensus projections, respectively as per <i>S&amp;P Capital IQ</i>.</p><p><b>Is Palantir Stock Expected To Rise Again?</b></p><p>I hold the view that Palantir&#39;s stock is expected to rise again when the company&#39;s Q3 2022 and Q4 2022 financial performance exceeds market expectations.</p><p>The market is skeptical about PTLR&#39;s ability to deliver on its full-year FY 2022 top line growth guidance of +30%. In comparison, the sell-side analysts&#39; consensus sales expansion estimate for Palantir is lower at +28.7%.</p><p>There are two key reasons why I think Palantir can achieve revenue beats for the second half of the year.</p><p>Firstly, PLTR should see its government revenue accelerate again in 2H 2022. The company&#39;s YoY government revenue growth decelerated from +26% in the fourth quarter of 2021 to +16% in the first quarter of 2022. Q1 2022 represented the fifth straight quarter running that Palantir&#39;s government revenue growth has slowed, but the trend is set to reverse. At its Q1 2022 results briefing, PLTR indicated that it is &#34;already seeing Q2 U.S. government revenue reaccelerate&#34; considering that &#34;a new budget has been passed&#34; in March 2022. A new US federal budget removes the uncertainty over the funding of future government projects, so it is natural to assume that PLTR&#39;s government revenue growth momentum will pick up pace in the second half of the year.</p><p>Secondly, the outlook for Palantir&#39;s commercial business is also good based on a review of the company&#39;s new customer additions for the recent quarter, given that there will be a time lag between new client wins and actual revenue recognition. PLTR&#39;s number of commercial clients grew by +207% YoY from 60 in Q1 2021 to 184 in Q1 2022, as per the company&#39;s recent quarterly results presentation slides. In the first quarter of this year alone, PLTR secured 37 new commercial clients (net of customers who left), which was equivalent to a very strong +25% QoQ growth. Palantir also disclosed at the company&#39;s first-quarter investor call that it &#34;closed a renewal with a major U.S. Fortune 100 company for over $150 million&#34; in April 2022. In other words, PLTR&#39;s commercial business is doing well, it is retaining key clients while adding new customers at a healthy pace.</p><p><b>Where Is Palantir Heading?</b></p><p>Palantir&#39;s shares should head north over the intermediate to long run, as investors appreciate the value of owning PLTR as a hedge against geopolitical tensions and conflicts.</p><p>PLTR emphasized at its earlier Q1 2022 results call that &#34;there&#39;s a wide range of potential upside above our guidance, including those driven by our role in responding to developing geopolitical events.&#34; The company&#39;s bullish view is validated by recently announced contract wins.</p><p>On June 28, 2022, <i>Seeking Alpha News</i> reported that the company &#34;and Raytheon Intelligence and Space (NYSE:RTX) have been awarded a prime contract to develop a prototype for the U.S. Army&#39;s Tactical Intelligence Targeting Access Node (TITAN) program.&#34; An earlier June 2, 2022 <i>Seeking Alpha News</i> article mentioned that PLTR was &#34;awarded a contract modification from the U.S. Space Systems Command&#34; so as to &#34;support national security objectives.&#34;</p><p>Palantir isn&#39;t just seeing more opportunities coming from US defense and government agencies.</p><p>Notably, PLTR secured a new $12.5 million deal from the United Kingdom&#39;s Ministry of Defense, according to a May 6, 2022 <i>Bloomberg</i> article, and it is reasonable to assume that rising geopolitical tensions in Europe following Russia - Ukraine war had compelled the UK Ministry of Defense to spend more which benefited Palantir. Separately, Palantir highlighted on its company&#39;s Twitter page on June 2, 2022 that its CEO had a meeting with Ukraine&#39;s president to discuss &#34;the pivotal role of software to Western security.&#34; It certainly seems that Palantir could win more defense-related contracts in Europe in the future.</p><p>As a reference, PLTR generated more than half or 57% of its fiscal 2021 revenue from the US markets, with key European markets, the UK and France, contributing a relatively lower 11% and 6% of its top line last year, respectively. Going forward, Palantir&#39;s actual top line growth could surpass expectations thanks to higher-than-expected sales contribution from Europe, especially in the area of defense.</p><p><b>Is PLTR Stock A Buy, Sell, or Hold?</b></p><p>I rate PLTR stock as a Buy. Faster-than-expected top line expansion in 2H 2022 and a larger-than-expected number of defense-related contract wins driven by geopolitical issues should be the key positive re-rating catalysts for Palantir.</p><p><i>This article was written by The Value Pendulum</i></p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Palantir Stock A Buy As It Nears All-Time Lows?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Palantir Stock A Buy As It Nears All-Time Lows?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-27 10:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4525634-is-palantir-stock-a-buy-nears-all-time-lows><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryPalantir's stock price has been under $10 for most of the May-July period, and it is currently trading at one-third of its 52-week peak.PLTR recorded an all-time low share price of $6.44 during...</p>\n\n<a href=\"https://seekingalpha.com/article/4525634-is-palantir-stock-a-buy-nears-all-time-lows\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://seekingalpha.com/article/4525634-is-palantir-stock-a-buy-nears-all-time-lows","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2254256508","content_text":"SummaryPalantir's stock price has been under $10 for most of the May-July period, and it is currently trading at one-third of its 52-week peak.PLTR recorded an all-time low share price of $6.44 during intra-day trading on May 12, 2022, as the company's Q2 2022 guidance released on May 9, 2022 disappointed the market.Palantir is a Buy now, because its 2H 2022 revenue should beat market expectations, and rising geopolitical tensions are a key driver of PLTR's medium-to-long term growth.Michael ViElevator PitchPalantir Technologies Inc. (NYSE:PLTR) is rated as a Buy.I did a comparison of PLTR with Snowflake Inc. (SNOW) in my earlier article published on April 8, 2022. In this recent update, I come to the conclusion that Palantir is a Buy now. PLTR is currently trading below $10 for the past three months or so, which means that the company's shares are back to where they were in the early days of its listing. This indicates that expectations for the company are low considering where its share price is, and Palantir is well-positioned to surprise the market with better-than-expected revenue growth in Q3 2022 and Q4 2022. More importantly, geopolitical tensions and conflicts are expected to drive an increase in the amount of money that governments around the world spend on defense, and Palantir is already a beneficiary as evidenced by recent contract wins.Why Is Palantir Stock Near All-Time Lows?Palantir debuted on the New York Stock Exchange on September 30, 2020 with its shares closing at $9.50 at the end of the trading day. PLTR's last done share price was $9.84 as of July 22, 2022, and the company's shares have been mostly trading below the $10 mark since early-May 2022, a sight last seen in late-2020.PLTR's Share Price Chart Since ListingSeeking AlphaPalantir set a new historical trough stock price of $6.44 during the May 12, 2022 trading day. Even though, the company's shares have risen from the lows, PLTR's closing price as of July 22 is still only a third of its 52-week high share price of $29.29.It isn't a big surprise that PLTR's shares are trading at such lows. The market is expecting Palantir to deliver more modest top line expansion while taking more time to generate positive GAAP earnings in the current weak economic environment. The sell-side's consensus financial forecasts obtained from S&P Capital IQ suggest that Palantir's revenue growth will moderate from above +40% for both fiscal 2020 and 2021 to below +30% for the FY 2022-2024 period. At the same time, PLTR is projected to stay loss-making on a GAAP basis in FY 2022 and FY 2023 at the very least.In uncertain times like these, investors tend to favor profitable companies boasting predictable (albeit relatively lower) sales growth. This also means that companies like PLTR which are still unprofitable on a GAAP basis and are witnessing revenue growth deceleration will be penalized by the market. In that respect, Palantir's consensus forward next twelve months' Enterprise Value-to-Revenue multiple has compressed from as high as 50 times in early- 2021 to under 10 times in the last three months as per S&P Capital IQ.PLTR Stock Key MetricsPLTR's below-expectations 2Q 2022 management guidance revealed as part of the company's Q1 2022 financial results released on May 9, 2022 was the key factor that led to Palantir's shares falling to a historical low on May 12, 2022.Palantir guided for the company to achieve a top line of $470 million and a non-GAAP adjusted operating profit margin of 20% for the second quarter of fiscal 2022. This implies that PLTR's revenue growth is forecasted to slow from +31% YoY in Q1 2022 to 25% YoY in Q2 2022, while its non-GAAP operating margin is estimated to contract from 26% to 20% over the same period.Moreover, PLTR's guided Q2 2022 revenue and operating profit margin were -4% and -6.8 percentage points below the market's consensus projections, respectively as per S&P Capital IQ.Is Palantir Stock Expected To Rise Again?I hold the view that Palantir's stock is expected to rise again when the company's Q3 2022 and Q4 2022 financial performance exceeds market expectations.The market is skeptical about PTLR's ability to deliver on its full-year FY 2022 top line growth guidance of +30%. In comparison, the sell-side analysts' consensus sales expansion estimate for Palantir is lower at +28.7%.There are two key reasons why I think Palantir can achieve revenue beats for the second half of the year.Firstly, PLTR should see its government revenue accelerate again in 2H 2022. The company's YoY government revenue growth decelerated from +26% in the fourth quarter of 2021 to +16% in the first quarter of 2022. Q1 2022 represented the fifth straight quarter running that Palantir's government revenue growth has slowed, but the trend is set to reverse. At its Q1 2022 results briefing, PLTR indicated that it is \"already seeing Q2 U.S. government revenue reaccelerate\" considering that \"a new budget has been passed\" in March 2022. A new US federal budget removes the uncertainty over the funding of future government projects, so it is natural to assume that PLTR's government revenue growth momentum will pick up pace in the second half of the year.Secondly, the outlook for Palantir's commercial business is also good based on a review of the company's new customer additions for the recent quarter, given that there will be a time lag between new client wins and actual revenue recognition. PLTR's number of commercial clients grew by +207% YoY from 60 in Q1 2021 to 184 in Q1 2022, as per the company's recent quarterly results presentation slides. In the first quarter of this year alone, PLTR secured 37 new commercial clients (net of customers who left), which was equivalent to a very strong +25% QoQ growth. Palantir also disclosed at the company's first-quarter investor call that it \"closed a renewal with a major U.S. Fortune 100 company for over $150 million\" in April 2022. In other words, PLTR's commercial business is doing well, it is retaining key clients while adding new customers at a healthy pace.Where Is Palantir Heading?Palantir's shares should head north over the intermediate to long run, as investors appreciate the value of owning PLTR as a hedge against geopolitical tensions and conflicts.PLTR emphasized at its earlier Q1 2022 results call that \"there's a wide range of potential upside above our guidance, including those driven by our role in responding to developing geopolitical events.\" The company's bullish view is validated by recently announced contract wins.On June 28, 2022, Seeking Alpha News reported that the company \"and Raytheon Intelligence and Space (NYSE:RTX) have been awarded a prime contract to develop a prototype for the U.S. Army's Tactical Intelligence Targeting Access Node (TITAN) program.\" An earlier June 2, 2022 Seeking Alpha News article mentioned that PLTR was \"awarded a contract modification from the U.S. Space Systems Command\" so as to \"support national security objectives.\"Palantir isn't just seeing more opportunities coming from US defense and government agencies.Notably, PLTR secured a new $12.5 million deal from the United Kingdom's Ministry of Defense, according to a May 6, 2022 Bloomberg article, and it is reasonable to assume that rising geopolitical tensions in Europe following Russia - Ukraine war had compelled the UK Ministry of Defense to spend more which benefited Palantir. Separately, Palantir highlighted on its company's Twitter page on June 2, 2022 that its CEO had a meeting with Ukraine's president to discuss \"the pivotal role of software to Western security.\" It certainly seems that Palantir could win more defense-related contracts in Europe in the future.As a reference, PLTR generated more than half or 57% of its fiscal 2021 revenue from the US markets, with key European markets, the UK and France, contributing a relatively lower 11% and 6% of its top line last year, respectively. Going forward, Palantir's actual top line growth could surpass expectations thanks to higher-than-expected sales contribution from Europe, especially in the area of defense.Is PLTR Stock A Buy, Sell, or Hold?I rate PLTR stock as a Buy. Faster-than-expected top line expansion in 2H 2022 and a larger-than-expected number of defense-related contract wins driven by geopolitical issues should be the key positive re-rating catalysts for Palantir.This article was written by The Value Pendulum","news_type":1},"isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9000163111,"gmtCreate":1640019768123,"gmtModify":1676533498527,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"Gogogo","listText":"Gogogo","text":"Gogogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000163111","repostId":"2192962184","repostType":2,"repost":{"id":"2192962184","pubTimestamp":1640004360,"share":"https://ttm.financial/m/news/2192962184?lang=&edition=fundamental","pubTime":"2021-12-20 20:46","market":"us","language":"en","title":"Palantir and Dewpoint Therapeutics Announce Strategic Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2192962184","media":"Business Wire","summary":"DENVER & BOSTON, December 20, 2021--(BUSINESS WIRE)--Palantir Technologies Inc. (NYSE: PLTR), a lead","content":"<p><b>DENVER &amp; BOSTON, December 20, 2021</b>--(BUSINESS WIRE)--<a href=\"https://laohu8.com/S/PLTR\">Palantir Technologies Inc.</a> (NYSE: PLTR), a leading builder of operating systems for the modern enterprise, and Dewpoint Therapeutics (\"Dewpoint\"), the leading biomolecular condensates company, today announced a partnership for Palantir’s Foundry platform to help power Dewpoint’s efforts to discover treatments and cures for the most challenging diseases.</p>\n<p>Palantir Foundry will help to enable researchers at Dewpoint to further their understanding of condensates biology by analyzing lab data along with other data sources, including data from the published literature and databases, to identify new compounds and therapeutic approaches.</p>\n<p>Dewpoint will also use Foundry as the primary platform for its centralized knowledge repository, helping it contextualize its experimental results and prioritize the most viable outcomes. This multi-year agreement marks <a href=\"https://laohu8.com/S/AONE.U\">one</a> of Palantir’s most comprehensive partnerships with a biotechnology company.</p>\n<p>Palantir Foundry is designed to integrate disparate and siloed information sources to lead to data-driven analysis and decision making. It allows users to track lineage across systems, making it particularly suited for work in life sciences and the biotechnology sector, where data sources come from several unique and separate systems.</p>\n<p>At Dewpoint, Foundry will be able to work seamlessly with the existing systems in its laboratories to provide researchers with a comprehensive foundation for exploration and analysis.</p>\n<p>\"We think Dewpoint is changing the way the world approaches drug design by exploring new frontiers of disease biology, requiring a game changing solution that goes beyond just cloud and infrastructure to drive their R&amp;D and scale with their vision as they grow,\" said Lalarukh Haris Shaikh, Palantir’s Head of Biotech. \"We are proud to partner with Dewpoint and share their passion of working on one of the most exciting translational medicine approaches of our time.\"</p>\n<p>Foundry will help researchers make decisions around compound and target viability and streamline experiments and automate analysis by creating a digital twin of the research environment. One concrete example of Foundry’s use at Dewpoint Therapeutics is the expansion of the data foundation to include advanced genetic analysis for disease association and correlation with condensate content, empowering future discoveries.</p>\n<p>\"Key to our approach has been creating a seamless connection between our wet-lab and dry-lab capabilities, with machine learning and AI at the center. Foundry has provided us with a solid foundation for us to fully connect and operationalize our entire lab to enterprise and enable the discovery and development of new drugs,\" said Dewpoint CEO Ameet Nathwani.</p>\n<p><b>About Biomolecular Condensates</b></p>\n<p>Biomolecular condensates, formed through a process called phase separation, are membraneless droplets inside cells that facilitate molecular interactions and help cells perform vital functions. Condensates have been shown to play a critical role in key biological processes and in serious, intractable diseases across areas including neurodegeneration, cancer, inflammation, infectious disease, metabolic disease, and rare genetic disorders. The first condensates were observed more than 100 years ago. It is only in the last dozen years, though, that scientists—including Dewpoint founders Tony Hyman of the Max Planck Institute in Dresden and Rick Young of the Whitehead Institute—have begun to understand the dynamic nature and function of condensates. Dewpoint develops drugs that exploit this biology.</p>\n<p><b>About Dewpoint Therapeutics</b></p>\n<p>Dewpoint Therapeutics is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions have pathways that are regulated by condensates or arise from the dysfunction of condensates — including cancer, neurodegeneration, infectious disease, and metabolic disease. Dewpoint scientists work in Boston, Dresden, and Berlin to translate condensate biology into treatments for the toughest diseases. Learn more at dewpointx.com, and follow us on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> and LinkedIn.</p>\n<p><b>About Palantir Technologies Inc.</b></p>\n<p>Palantir Technologies Inc. builds and deploys operating systems for the modern enterprise. Additional information is available at https://www.palantir.com.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir and Dewpoint Therapeutics Announce Strategic Partnership</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir and Dewpoint Therapeutics Announce Strategic Partnership\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 20:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/palantir-dewpoint-therapeutics-announce-strategic-115900746.html><strong>Business Wire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DENVER & BOSTON, December 20, 2021--(BUSINESS WIRE)--Palantir Technologies Inc. (NYSE: PLTR), a leading builder of operating systems for the modern enterprise, and Dewpoint Therapeutics (\"Dewpoint\"), ...</p>\n\n<a href=\"https://finance.yahoo.com/news/palantir-dewpoint-therapeutics-announce-strategic-115900746.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4023":"应用软件","BK4543":"AI","BK4547":"WSB热门概念","PLTR":"Palantir Technologies Inc."},"source_url":"https://finance.yahoo.com/news/palantir-dewpoint-therapeutics-announce-strategic-115900746.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2192962184","content_text":"DENVER & BOSTON, December 20, 2021--(BUSINESS WIRE)--Palantir Technologies Inc. (NYSE: PLTR), a leading builder of operating systems for the modern enterprise, and Dewpoint Therapeutics (\"Dewpoint\"), the leading biomolecular condensates company, today announced a partnership for Palantir’s Foundry platform to help power Dewpoint’s efforts to discover treatments and cures for the most challenging diseases.\nPalantir Foundry will help to enable researchers at Dewpoint to further their understanding of condensates biology by analyzing lab data along with other data sources, including data from the published literature and databases, to identify new compounds and therapeutic approaches.\nDewpoint will also use Foundry as the primary platform for its centralized knowledge repository, helping it contextualize its experimental results and prioritize the most viable outcomes. This multi-year agreement marks one of Palantir’s most comprehensive partnerships with a biotechnology company.\nPalantir Foundry is designed to integrate disparate and siloed information sources to lead to data-driven analysis and decision making. It allows users to track lineage across systems, making it particularly suited for work in life sciences and the biotechnology sector, where data sources come from several unique and separate systems.\nAt Dewpoint, Foundry will be able to work seamlessly with the existing systems in its laboratories to provide researchers with a comprehensive foundation for exploration and analysis.\n\"We think Dewpoint is changing the way the world approaches drug design by exploring new frontiers of disease biology, requiring a game changing solution that goes beyond just cloud and infrastructure to drive their R&D and scale with their vision as they grow,\" said Lalarukh Haris Shaikh, Palantir’s Head of Biotech. \"We are proud to partner with Dewpoint and share their passion of working on one of the most exciting translational medicine approaches of our time.\"\nFoundry will help researchers make decisions around compound and target viability and streamline experiments and automate analysis by creating a digital twin of the research environment. One concrete example of Foundry’s use at Dewpoint Therapeutics is the expansion of the data foundation to include advanced genetic analysis for disease association and correlation with condensate content, empowering future discoveries.\n\"Key to our approach has been creating a seamless connection between our wet-lab and dry-lab capabilities, with machine learning and AI at the center. Foundry has provided us with a solid foundation for us to fully connect and operationalize our entire lab to enterprise and enable the discovery and development of new drugs,\" said Dewpoint CEO Ameet Nathwani.\nAbout Biomolecular Condensates\nBiomolecular condensates, formed through a process called phase separation, are membraneless droplets inside cells that facilitate molecular interactions and help cells perform vital functions. Condensates have been shown to play a critical role in key biological processes and in serious, intractable diseases across areas including neurodegeneration, cancer, inflammation, infectious disease, metabolic disease, and rare genetic disorders. The first condensates were observed more than 100 years ago. It is only in the last dozen years, though, that scientists—including Dewpoint founders Tony Hyman of the Max Planck Institute in Dresden and Rick Young of the Whitehead Institute—have begun to understand the dynamic nature and function of condensates. Dewpoint develops drugs that exploit this biology.\nAbout Dewpoint Therapeutics\nDewpoint Therapeutics is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions have pathways that are regulated by condensates or arise from the dysfunction of condensates — including cancer, neurodegeneration, infectious disease, and metabolic disease. Dewpoint scientists work in Boston, Dresden, and Berlin to translate condensate biology into treatments for the toughest diseases. Learn more at dewpointx.com, and follow us on Twitter and LinkedIn.\nAbout Palantir Technologies Inc.\nPalantir Technologies Inc. builds and deploys operating systems for the modern enterprise. Additional information is available at https://www.palantir.com.","news_type":1},"isVote":1,"tweetType":1,"viewCount":247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":358052543648136,"gmtCreate":1728451957883,"gmtModify":1728473997376,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> Best investment of my life","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> Best investment of my life","text":"$Palantir Technologies Inc.(PLTR)$ Best investment of my life","images":[{"img":"https://community-static.tradeup.com/news/387a496b3a6d3e92da13946f324ae091","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/358052543648136","isVote":1,"tweetType":1,"viewCount":919,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":273985532768496,"gmtCreate":1707928970141,"gmtModify":1707958195611,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a> LFG","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a> LFG","text":"$Palantir Technologies Inc.(PLTR)$ LFG","images":[{"img":"https://community-static.tradeup.com/news/5f067879f39aee6fa118f9ac26ac3447","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/273985532768496","isVote":1,"tweetType":1,"viewCount":375,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":328117935337528,"gmtCreate":1721136977959,"gmtModify":1721137026216,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"Every time we have nice things some dumb fucking analyst comes and f&nbsp;it up","listText":"Every time we have nice things some dumb fucking analyst comes and f&nbsp;it up","text":"Every time we have nice things some dumb fucking analyst comes and f it up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/328117935337528","repostId":"1162176667","repostType":2,"repost":{"id":"1162176667","pubTimestamp":1721136900,"share":"https://ttm.financial/m/news/1162176667?lang=&edition=fundamental","pubTime":"2024-07-16 21:35","market":"us","language":"en","title":"Palantir Slips 3% Following Ratings Downgrade from Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=1162176667","media":"Seeking Alpha","summary":"Palantir Technologies slipped nearly 3% in morning trading Tuesday after being downgraded to Underperform from Neutral by Mizuho Securities.Although Palantir has performed well in recent quarters, Miz","content":"<html><head></head><body><p>Palantir Technologies slipped nearly 3% in morning trading Tuesday after being downgraded to Underperform from Neutral by Mizuho Securities.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/f69bfd5e8314b7d2b924705c598f1307\" tg-width=\"874\" tg-height=\"622\"/></p><p style=\"text-align: left;\">Although Palantir has performed well in recent quarters, Mizuho analysts doubt whether the big data analytics software firm can maintain these results.</p><p style=\"text-align: left;\">&#34;But primarily, following the material 67% rise in the shares YTD, we find it increasingly difficult to justify PLTR&#39;s high multiple (21x CY25E revenue) that, in our view, likely already discounts significant acceleration versus our consensus expectations for 20-21% revenue growth,&#34; said Mizuho analysts led by Gregg Moskowitz, in a note.</p><p style=\"text-align: left;\">However, Mizuho slightly increased the price target on the Denver-based firm to $22 from $21.</p><p style=\"text-align: left;\">&#34;There are some exciting aspects of the PLTR story (megadeals, AIP), although this is offset by a lack of transparency and a likelihood of lumpy results going forward, in our view,&#34; Moskowitz added. &#34;Net, we have limited confidence in the company&#39;s ability to deliver consistently strong results and accelerating growth, which is needed to justify the premium valuation.&#34;</p><p style=\"text-align: left;\">Palantir has a Hold rating from Seeking Alpha analysts, Wall Street analysts and Seeking Alpha&#39;s Quant system, which routinely beats the market.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir Slips 3% Following Ratings Downgrade from Mizuho</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir Slips 3% Following Ratings Downgrade from Mizuho\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-16 21:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4124573-palantir-slips-pre-market-following-ratings-downgrade-from-mizuho><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Palantir Technologies slipped nearly 3% in morning trading Tuesday after being downgraded to Underperform from Neutral by Mizuho Securities.Although Palantir has performed well in recent quarters, ...</p>\n\n<a href=\"https://seekingalpha.com/news/4124573-palantir-slips-pre-market-following-ratings-downgrade-from-mizuho\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://seekingalpha.com/news/4124573-palantir-slips-pre-market-following-ratings-downgrade-from-mizuho","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1162176667","content_text":"Palantir Technologies slipped nearly 3% in morning trading Tuesday after being downgraded to Underperform from Neutral by Mizuho Securities.Although Palantir has performed well in recent quarters, Mizuho analysts doubt whether the big data analytics software firm can maintain these results.\"But primarily, following the material 67% rise in the shares YTD, we find it increasingly difficult to justify PLTR's high multiple (21x CY25E revenue) that, in our view, likely already discounts significant acceleration versus our consensus expectations for 20-21% revenue growth,\" said Mizuho analysts led by Gregg Moskowitz, in a note.However, Mizuho slightly increased the price target on the Denver-based firm to $22 from $21.\"There are some exciting aspects of the PLTR story (megadeals, AIP), although this is offset by a lack of transparency and a likelihood of lumpy results going forward, in our view,\" Moskowitz added. \"Net, we have limited confidence in the company's ability to deliver consistently strong results and accelerating growth, which is needed to justify the premium valuation.\"Palantir has a Hold rating from Seeking Alpha analysts, Wall Street analysts and Seeking Alpha's Quant system, which routinely beats the market.","news_type":1},"isVote":1,"tweetType":1,"viewCount":230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":324236008308760,"gmtCreate":1720188385426,"gmtModify":1720188389878,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> oh my god! Let's go!","listText":"<a href=\"https://ttm.financial/S/PLTR\">$(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> oh my god! Let's go!","text":"$(PLTR)$ oh my god! Let's go!","images":[{"img":"https://community-static.tradeup.com/news/9fb9e88b1b58e5c7f970910f728b2512","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/324236008308760","isVote":1,"tweetType":1,"viewCount":410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":335302235058312,"gmtCreate":1722890861188,"gmtModify":1722890866689,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> Solid earning report! Congrats to all the shareholders! Keep believing in Karp!","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> Solid earning report! Congrats to all the shareholders! Keep believing in Karp!","text":"$Palantir Technologies Inc.(PLTR)$ Solid earning report! Congrats to all the shareholders! Keep believing in Karp!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/335302235058312","isVote":1,"tweetType":1,"viewCount":198,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":325664432181320,"gmtCreate":1720531966447,"gmtModify":1720532011342,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> In Karp we trust&nbsp;","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> In Karp we trust&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$ In Karp we trust","images":[{"img":"https://community-static.tradeup.com/news/a6f823ea775ca5dab2297475761c2a69","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325664432181320","isVote":1,"tweetType":1,"viewCount":410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":328854834770136,"gmtCreate":1721312042407,"gmtModify":1721382115249,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> new 52w high again! Stonk!","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> new 52w high again! Stonk!","text":"$Palantir Technologies Inc.(PLTR)$ new 52w high again! Stonk!","images":[{"img":"https://community-static.tradeup.com/news/7f5d05558b3629c234c28e343c445444","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/328854834770136","isVote":1,"tweetType":1,"viewCount":268,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":278953580851360,"gmtCreate":1709125514055,"gmtModify":1709127904834,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> LFG!!","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> LFG!!","text":"$Palantir Technologies Inc.(PLTR)$ LFG!!","images":[{"img":"https://community-static.tradeup.com/news/7fc81ab794fd2a52506d7364d1bdb4bc","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/278953580851360","isVote":1,"tweetType":1,"viewCount":245,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":356165444690304,"gmtCreate":1727963929454,"gmtModify":1727963991459,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> Milestone HIT! 🚀🚀🚀 💎💎💎","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> Milestone HIT! 🚀🚀🚀 💎💎💎","text":"$Palantir Technologies Inc.(PLTR)$ Milestone HIT! 🚀🚀🚀 💎💎💎","images":[{"img":"https://community-static.tradeup.com/news/6dc62068ca3941bd829a78bd1ea04ecd","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/356165444690304","isVote":1,"tweetType":1,"viewCount":138,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":351097361915912,"gmtCreate":1726739607578,"gmtModify":1726739610581,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$","images":[{"img":"https://community-static.tradeup.com/news/73f54711475004d336ec2234769054ec","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/351097361915912","isVote":1,"tweetType":1,"viewCount":39,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":335472655327440,"gmtCreate":1722932347233,"gmtModify":1722932350590,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> In Karp we trust","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> In Karp we trust","text":"$Palantir Technologies Inc.(PLTR)$ In Karp we trust","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/335472655327440","isVote":1,"tweetType":1,"viewCount":198,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":303305394200792,"gmtCreate":1715069508611,"gmtModify":1715069510947,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/303305394200792","isVote":1,"tweetType":1,"viewCount":494,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9909437020,"gmtCreate":1658901740860,"gmtModify":1676536226773,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9909437020","repostId":"2254256508","repostType":2,"repost":{"id":"2254256508","pubTimestamp":1658889304,"share":"https://ttm.financial/m/news/2254256508?lang=&edition=fundamental","pubTime":"2022-07-27 10:35","market":"us","language":"en","title":"Is Palantir Stock A Buy As It Nears All-Time Lows?","url":"https://stock-news.laohu8.com/highlight/detail?id=2254256508","media":"seekingalpha","summary":"SummaryPalantir's stock price has been under $10 for most of the May-July period, and it is currentl","content":"<html><head></head><body><p><b>Summary</b></p><ul><li>Palantir&#39;s stock price has been under $10 for most of the May-July period, and it is currently trading at one-third of its 52-week peak.</li><li>PLTR recorded an all-time low share price of $6.44 during intra-day trading on May 12, 2022, as the company&#39;s Q2 2022 guidance released on May 9, 2022 disappointed the market.</li><li>Palantir is a Buy now, because its 2H 2022 revenue should beat market expectations, and rising geopolitical tensions are a key driver of PLTR&#39;s medium-to-long term growth.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/23d0f121f38325521c0b8ebbb42b26b3\" tg-width=\"750\" tg-height=\"500\" referrerpolicy=\"no-referrer\"/><span>Michael Vi</span></p><p><b>Elevator Pitch</b></p><p><a href=\"https://laohu8.com/S/PLTR\">Palantir Technologies Inc.</a> (NYSE:PLTR) is rated as a Buy.</p><p>I did a comparison of PLTR with <a href=\"https://laohu8.com/S/SNOW\">Snowflake</a> Inc. (SNOW) in my earlier article published on April 8, 2022. In this recent update, I come to the conclusion that Palantir is a Buy now. PLTR is currently trading below $10 for the past three months or so, which means that the company&#39;s shares are back to where they were in the early days of its listing. This indicates that expectations for the company are low considering where its share price is, and Palantir is well-positioned to surprise the market with better-than-expected revenue growth in Q3 2022 and Q4 2022. More importantly, geopolitical tensions and conflicts are expected to drive an increase in the amount of money that governments around the world spend on defense, and Palantir is already a beneficiary as evidenced by recent contract wins.</p><p>Why Is Palantir Stock Near All-Time Lows?</p><p>Palantir debuted on the New York Stock Exchange on September 30, 2020 with its shares closing at $9.50 at the end of the trading day. PLTR&#39;s last done share price was $9.84 as of July 22, 2022, and the company&#39;s shares have been mostly trading below the $10 mark since early-May 2022, a sight last seen in late-2020.</p><p><b>PLTR&#39;s Share Price Chart Since Listing</b></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/eaf8580ab0adcab20086c9a2fbd22934\" tg-width=\"640\" tg-height=\"227\" referrerpolicy=\"no-referrer\"/><span>Seeking Alpha</span></p><p>Palantir set a new historical trough stock price of $6.44 during the May 12, 2022 trading day. Even though, the company&#39;s shares have risen from the lows, PLTR&#39;s closing price as of July 22 is still only a third of its 52-week high share price of $29.29.</p><p>It isn&#39;t a big surprise that PLTR&#39;s shares are trading at such lows. The market is expecting Palantir to deliver more modest top line expansion while taking more time to generate positive GAAP earnings in the current weak economic environment. The sell-side&#39;s consensus financial forecasts obtained from <i>S&amp;P Capital IQ</i> suggest that Palantir&#39;s revenue growth will moderate from above +40% for both fiscal 2020 and 2021 to below +30% for the FY 2022-2024 period. At the same time, PLTR is projected to stay loss-making on a GAAP basis in FY 2022 and FY 2023 at the very least.</p><p>In uncertain times like these, investors tend to favor profitable companies boasting predictable (albeit relatively lower) sales growth. This also means that companies like PLTR which are still unprofitable on a GAAP basis and are witnessing revenue growth deceleration will be penalized by the market. In that respect, Palantir&#39;s consensus forward next twelve months&#39; Enterprise Value-to-Revenue multiple has compressed from as high as 50 times in early- 2021 to under 10 times in the last three months as per <i>S&amp;P Capital IQ</i>.</p><p><b>PLTR Stock Key Metrics</b></p><p>PLTR&#39;s below-expectations 2Q 2022 management guidance revealed as part of the company&#39;s Q1 2022 financial results released on May 9, 2022 was the key factor that led to Palantir&#39;s shares falling to a historical low on May 12, 2022.</p><p>Palantir guided for the company to achieve a top line of $470 million and a non-GAAP adjusted operating profit margin of 20% for the second quarter of fiscal 2022. This implies that PLTR&#39;s revenue growth is forecasted to slow from +31% YoY in Q1 2022 to 25% YoY in Q2 2022, while its non-GAAP operating margin is estimated to contract from 26% to 20% over the same period.</p><p>Moreover, PLTR&#39;s guided Q2 2022 revenue and operating profit margin were -4% and -6.8 percentage points below the market&#39;s consensus projections, respectively as per <i>S&amp;P Capital IQ</i>.</p><p><b>Is Palantir Stock Expected To Rise Again?</b></p><p>I hold the view that Palantir&#39;s stock is expected to rise again when the company&#39;s Q3 2022 and Q4 2022 financial performance exceeds market expectations.</p><p>The market is skeptical about PTLR&#39;s ability to deliver on its full-year FY 2022 top line growth guidance of +30%. In comparison, the sell-side analysts&#39; consensus sales expansion estimate for Palantir is lower at +28.7%.</p><p>There are two key reasons why I think Palantir can achieve revenue beats for the second half of the year.</p><p>Firstly, PLTR should see its government revenue accelerate again in 2H 2022. The company&#39;s YoY government revenue growth decelerated from +26% in the fourth quarter of 2021 to +16% in the first quarter of 2022. Q1 2022 represented the fifth straight quarter running that Palantir&#39;s government revenue growth has slowed, but the trend is set to reverse. At its Q1 2022 results briefing, PLTR indicated that it is &#34;already seeing Q2 U.S. government revenue reaccelerate&#34; considering that &#34;a new budget has been passed&#34; in March 2022. A new US federal budget removes the uncertainty over the funding of future government projects, so it is natural to assume that PLTR&#39;s government revenue growth momentum will pick up pace in the second half of the year.</p><p>Secondly, the outlook for Palantir&#39;s commercial business is also good based on a review of the company&#39;s new customer additions for the recent quarter, given that there will be a time lag between new client wins and actual revenue recognition. PLTR&#39;s number of commercial clients grew by +207% YoY from 60 in Q1 2021 to 184 in Q1 2022, as per the company&#39;s recent quarterly results presentation slides. In the first quarter of this year alone, PLTR secured 37 new commercial clients (net of customers who left), which was equivalent to a very strong +25% QoQ growth. Palantir also disclosed at the company&#39;s first-quarter investor call that it &#34;closed a renewal with a major U.S. Fortune 100 company for over $150 million&#34; in April 2022. In other words, PLTR&#39;s commercial business is doing well, it is retaining key clients while adding new customers at a healthy pace.</p><p><b>Where Is Palantir Heading?</b></p><p>Palantir&#39;s shares should head north over the intermediate to long run, as investors appreciate the value of owning PLTR as a hedge against geopolitical tensions and conflicts.</p><p>PLTR emphasized at its earlier Q1 2022 results call that &#34;there&#39;s a wide range of potential upside above our guidance, including those driven by our role in responding to developing geopolitical events.&#34; The company&#39;s bullish view is validated by recently announced contract wins.</p><p>On June 28, 2022, <i>Seeking Alpha News</i> reported that the company &#34;and Raytheon Intelligence and Space (NYSE:RTX) have been awarded a prime contract to develop a prototype for the U.S. Army&#39;s Tactical Intelligence Targeting Access Node (TITAN) program.&#34; An earlier June 2, 2022 <i>Seeking Alpha News</i> article mentioned that PLTR was &#34;awarded a contract modification from the U.S. Space Systems Command&#34; so as to &#34;support national security objectives.&#34;</p><p>Palantir isn&#39;t just seeing more opportunities coming from US defense and government agencies.</p><p>Notably, PLTR secured a new $12.5 million deal from the United Kingdom&#39;s Ministry of Defense, according to a May 6, 2022 <i>Bloomberg</i> article, and it is reasonable to assume that rising geopolitical tensions in Europe following Russia - Ukraine war had compelled the UK Ministry of Defense to spend more which benefited Palantir. Separately, Palantir highlighted on its company&#39;s Twitter page on June 2, 2022 that its CEO had a meeting with Ukraine&#39;s president to discuss &#34;the pivotal role of software to Western security.&#34; It certainly seems that Palantir could win more defense-related contracts in Europe in the future.</p><p>As a reference, PLTR generated more than half or 57% of its fiscal 2021 revenue from the US markets, with key European markets, the UK and France, contributing a relatively lower 11% and 6% of its top line last year, respectively. Going forward, Palantir&#39;s actual top line growth could surpass expectations thanks to higher-than-expected sales contribution from Europe, especially in the area of defense.</p><p><b>Is PLTR Stock A Buy, Sell, or Hold?</b></p><p>I rate PLTR stock as a Buy. Faster-than-expected top line expansion in 2H 2022 and a larger-than-expected number of defense-related contract wins driven by geopolitical issues should be the key positive re-rating catalysts for Palantir.</p><p><i>This article was written by The Value Pendulum</i></p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Palantir Stock A Buy As It Nears All-Time Lows?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Palantir Stock A Buy As It Nears All-Time Lows?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-27 10:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4525634-is-palantir-stock-a-buy-nears-all-time-lows><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryPalantir's stock price has been under $10 for most of the May-July period, and it is currently trading at one-third of its 52-week peak.PLTR recorded an all-time low share price of $6.44 during...</p>\n\n<a href=\"https://seekingalpha.com/article/4525634-is-palantir-stock-a-buy-nears-all-time-lows\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://seekingalpha.com/article/4525634-is-palantir-stock-a-buy-nears-all-time-lows","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2254256508","content_text":"SummaryPalantir's stock price has been under $10 for most of the May-July period, and it is currently trading at one-third of its 52-week peak.PLTR recorded an all-time low share price of $6.44 during intra-day trading on May 12, 2022, as the company's Q2 2022 guidance released on May 9, 2022 disappointed the market.Palantir is a Buy now, because its 2H 2022 revenue should beat market expectations, and rising geopolitical tensions are a key driver of PLTR's medium-to-long term growth.Michael ViElevator PitchPalantir Technologies Inc. (NYSE:PLTR) is rated as a Buy.I did a comparison of PLTR with Snowflake Inc. (SNOW) in my earlier article published on April 8, 2022. In this recent update, I come to the conclusion that Palantir is a Buy now. PLTR is currently trading below $10 for the past three months or so, which means that the company's shares are back to where they were in the early days of its listing. This indicates that expectations for the company are low considering where its share price is, and Palantir is well-positioned to surprise the market with better-than-expected revenue growth in Q3 2022 and Q4 2022. More importantly, geopolitical tensions and conflicts are expected to drive an increase in the amount of money that governments around the world spend on defense, and Palantir is already a beneficiary as evidenced by recent contract wins.Why Is Palantir Stock Near All-Time Lows?Palantir debuted on the New York Stock Exchange on September 30, 2020 with its shares closing at $9.50 at the end of the trading day. PLTR's last done share price was $9.84 as of July 22, 2022, and the company's shares have been mostly trading below the $10 mark since early-May 2022, a sight last seen in late-2020.PLTR's Share Price Chart Since ListingSeeking AlphaPalantir set a new historical trough stock price of $6.44 during the May 12, 2022 trading day. Even though, the company's shares have risen from the lows, PLTR's closing price as of July 22 is still only a third of its 52-week high share price of $29.29.It isn't a big surprise that PLTR's shares are trading at such lows. The market is expecting Palantir to deliver more modest top line expansion while taking more time to generate positive GAAP earnings in the current weak economic environment. The sell-side's consensus financial forecasts obtained from S&P Capital IQ suggest that Palantir's revenue growth will moderate from above +40% for both fiscal 2020 and 2021 to below +30% for the FY 2022-2024 period. At the same time, PLTR is projected to stay loss-making on a GAAP basis in FY 2022 and FY 2023 at the very least.In uncertain times like these, investors tend to favor profitable companies boasting predictable (albeit relatively lower) sales growth. This also means that companies like PLTR which are still unprofitable on a GAAP basis and are witnessing revenue growth deceleration will be penalized by the market. In that respect, Palantir's consensus forward next twelve months' Enterprise Value-to-Revenue multiple has compressed from as high as 50 times in early- 2021 to under 10 times in the last three months as per S&P Capital IQ.PLTR Stock Key MetricsPLTR's below-expectations 2Q 2022 management guidance revealed as part of the company's Q1 2022 financial results released on May 9, 2022 was the key factor that led to Palantir's shares falling to a historical low on May 12, 2022.Palantir guided for the company to achieve a top line of $470 million and a non-GAAP adjusted operating profit margin of 20% for the second quarter of fiscal 2022. This implies that PLTR's revenue growth is forecasted to slow from +31% YoY in Q1 2022 to 25% YoY in Q2 2022, while its non-GAAP operating margin is estimated to contract from 26% to 20% over the same period.Moreover, PLTR's guided Q2 2022 revenue and operating profit margin were -4% and -6.8 percentage points below the market's consensus projections, respectively as per S&P Capital IQ.Is Palantir Stock Expected To Rise Again?I hold the view that Palantir's stock is expected to rise again when the company's Q3 2022 and Q4 2022 financial performance exceeds market expectations.The market is skeptical about PTLR's ability to deliver on its full-year FY 2022 top line growth guidance of +30%. In comparison, the sell-side analysts' consensus sales expansion estimate for Palantir is lower at +28.7%.There are two key reasons why I think Palantir can achieve revenue beats for the second half of the year.Firstly, PLTR should see its government revenue accelerate again in 2H 2022. The company's YoY government revenue growth decelerated from +26% in the fourth quarter of 2021 to +16% in the first quarter of 2022. Q1 2022 represented the fifth straight quarter running that Palantir's government revenue growth has slowed, but the trend is set to reverse. At its Q1 2022 results briefing, PLTR indicated that it is \"already seeing Q2 U.S. government revenue reaccelerate\" considering that \"a new budget has been passed\" in March 2022. A new US federal budget removes the uncertainty over the funding of future government projects, so it is natural to assume that PLTR's government revenue growth momentum will pick up pace in the second half of the year.Secondly, the outlook for Palantir's commercial business is also good based on a review of the company's new customer additions for the recent quarter, given that there will be a time lag between new client wins and actual revenue recognition. PLTR's number of commercial clients grew by +207% YoY from 60 in Q1 2021 to 184 in Q1 2022, as per the company's recent quarterly results presentation slides. In the first quarter of this year alone, PLTR secured 37 new commercial clients (net of customers who left), which was equivalent to a very strong +25% QoQ growth. Palantir also disclosed at the company's first-quarter investor call that it \"closed a renewal with a major U.S. Fortune 100 company for over $150 million\" in April 2022. In other words, PLTR's commercial business is doing well, it is retaining key clients while adding new customers at a healthy pace.Where Is Palantir Heading?Palantir's shares should head north over the intermediate to long run, as investors appreciate the value of owning PLTR as a hedge against geopolitical tensions and conflicts.PLTR emphasized at its earlier Q1 2022 results call that \"there's a wide range of potential upside above our guidance, including those driven by our role in responding to developing geopolitical events.\" The company's bullish view is validated by recently announced contract wins.On June 28, 2022, Seeking Alpha News reported that the company \"and Raytheon Intelligence and Space (NYSE:RTX) have been awarded a prime contract to develop a prototype for the U.S. Army's Tactical Intelligence Targeting Access Node (TITAN) program.\" An earlier June 2, 2022 Seeking Alpha News article mentioned that PLTR was \"awarded a contract modification from the U.S. Space Systems Command\" so as to \"support national security objectives.\"Palantir isn't just seeing more opportunities coming from US defense and government agencies.Notably, PLTR secured a new $12.5 million deal from the United Kingdom's Ministry of Defense, according to a May 6, 2022 Bloomberg article, and it is reasonable to assume that rising geopolitical tensions in Europe following Russia - Ukraine war had compelled the UK Ministry of Defense to spend more which benefited Palantir. Separately, Palantir highlighted on its company's Twitter page on June 2, 2022 that its CEO had a meeting with Ukraine's president to discuss \"the pivotal role of software to Western security.\" It certainly seems that Palantir could win more defense-related contracts in Europe in the future.As a reference, PLTR generated more than half or 57% of its fiscal 2021 revenue from the US markets, with key European markets, the UK and France, contributing a relatively lower 11% and 6% of its top line last year, respectively. Going forward, Palantir's actual top line growth could surpass expectations thanks to higher-than-expected sales contribution from Europe, especially in the area of defense.Is PLTR Stock A Buy, Sell, or Hold?I rate PLTR stock as a Buy. Faster-than-expected top line expansion in 2H 2022 and a larger-than-expected number of defense-related contract wins driven by geopolitical issues should be the key positive re-rating catalysts for Palantir.This article was written by The Value Pendulum","news_type":1},"isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":336643815297128,"gmtCreate":1723224518881,"gmtModify":1723224522999,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$","images":[{"img":"https://community-static.tradeup.com/news/e69bf423a2e711db9f467dc6fe70fe4f","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/336643815297128","isVote":1,"tweetType":1,"viewCount":107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":336631816429952,"gmtCreate":1723223964592,"gmtModify":1723223969043,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> We finally hit the magic number $30! LFG!","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> We finally hit the magic number $30! LFG!","text":"$Palantir Technologies Inc.(PLTR)$ We finally hit the magic number $30! LFG!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/336631816429952","isVote":1,"tweetType":1,"viewCount":81,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329244912992416,"gmtCreate":1721387710194,"gmtModify":1721387714602,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"Thanks for the feature. Let’s hope palantir will go higher 🚀🚀🚀","listText":"Thanks for the feature. Let’s hope palantir will go higher 🚀🚀🚀","text":"Thanks for the feature. Let’s hope palantir will go higher 🚀🚀🚀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/329244912992416","isVote":1,"tweetType":1,"viewCount":260,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":326087482687560,"gmtCreate":1720635250261,"gmtModify":1720635306345,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> BULLISH!","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v> BULLISH!","text":"$Palantir Technologies Inc.(PLTR)$ BULLISH!","images":[{"img":"https://community-static.tradeup.com/news/7f9c9b913d6a690e917ed62c31d3fde3","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/326087482687560","isVote":1,"tweetType":1,"viewCount":354,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":318289363521656,"gmtCreate":1718734666175,"gmtModify":1718734669565,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$","images":[{"img":"https://community-static.tradeup.com/news/08f6fcaed0586b3978a2c94e45753b73","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/318289363521656","isVote":1,"tweetType":1,"viewCount":210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":282214718771320,"gmtCreate":1709908380804,"gmtModify":1709908384747,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$","images":[{"img":"https://community-static.tradeup.com/news/db1129be90521fe68e446a5d5ab97a4d","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/282214718771320","isVote":1,"tweetType":1,"viewCount":255,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9000163111,"gmtCreate":1640019768123,"gmtModify":1676533498527,"author":{"id":"4099388038790400","authorId":"4099388038790400","name":"shihou.hayashi","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4099388038790400","authorIdStr":"4099388038790400"},"themes":[],"htmlText":"Gogogo","listText":"Gogogo","text":"Gogogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000163111","repostId":"2192962184","repostType":2,"repost":{"id":"2192962184","pubTimestamp":1640004360,"share":"https://ttm.financial/m/news/2192962184?lang=&edition=fundamental","pubTime":"2021-12-20 20:46","market":"us","language":"en","title":"Palantir and Dewpoint Therapeutics Announce Strategic Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2192962184","media":"Business Wire","summary":"DENVER & BOSTON, December 20, 2021--(BUSINESS WIRE)--Palantir Technologies Inc. (NYSE: PLTR), a lead","content":"<p><b>DENVER &amp; BOSTON, December 20, 2021</b>--(BUSINESS WIRE)--<a href=\"https://laohu8.com/S/PLTR\">Palantir Technologies Inc.</a> (NYSE: PLTR), a leading builder of operating systems for the modern enterprise, and Dewpoint Therapeutics (\"Dewpoint\"), the leading biomolecular condensates company, today announced a partnership for Palantir’s Foundry platform to help power Dewpoint’s efforts to discover treatments and cures for the most challenging diseases.</p>\n<p>Palantir Foundry will help to enable researchers at Dewpoint to further their understanding of condensates biology by analyzing lab data along with other data sources, including data from the published literature and databases, to identify new compounds and therapeutic approaches.</p>\n<p>Dewpoint will also use Foundry as the primary platform for its centralized knowledge repository, helping it contextualize its experimental results and prioritize the most viable outcomes. This multi-year agreement marks <a href=\"https://laohu8.com/S/AONE.U\">one</a> of Palantir’s most comprehensive partnerships with a biotechnology company.</p>\n<p>Palantir Foundry is designed to integrate disparate and siloed information sources to lead to data-driven analysis and decision making. It allows users to track lineage across systems, making it particularly suited for work in life sciences and the biotechnology sector, where data sources come from several unique and separate systems.</p>\n<p>At Dewpoint, Foundry will be able to work seamlessly with the existing systems in its laboratories to provide researchers with a comprehensive foundation for exploration and analysis.</p>\n<p>\"We think Dewpoint is changing the way the world approaches drug design by exploring new frontiers of disease biology, requiring a game changing solution that goes beyond just cloud and infrastructure to drive their R&amp;D and scale with their vision as they grow,\" said Lalarukh Haris Shaikh, Palantir’s Head of Biotech. \"We are proud to partner with Dewpoint and share their passion of working on one of the most exciting translational medicine approaches of our time.\"</p>\n<p>Foundry will help researchers make decisions around compound and target viability and streamline experiments and automate analysis by creating a digital twin of the research environment. One concrete example of Foundry’s use at Dewpoint Therapeutics is the expansion of the data foundation to include advanced genetic analysis for disease association and correlation with condensate content, empowering future discoveries.</p>\n<p>\"Key to our approach has been creating a seamless connection between our wet-lab and dry-lab capabilities, with machine learning and AI at the center. Foundry has provided us with a solid foundation for us to fully connect and operationalize our entire lab to enterprise and enable the discovery and development of new drugs,\" said Dewpoint CEO Ameet Nathwani.</p>\n<p><b>About Biomolecular Condensates</b></p>\n<p>Biomolecular condensates, formed through a process called phase separation, are membraneless droplets inside cells that facilitate molecular interactions and help cells perform vital functions. Condensates have been shown to play a critical role in key biological processes and in serious, intractable diseases across areas including neurodegeneration, cancer, inflammation, infectious disease, metabolic disease, and rare genetic disorders. The first condensates were observed more than 100 years ago. It is only in the last dozen years, though, that scientists—including Dewpoint founders Tony Hyman of the Max Planck Institute in Dresden and Rick Young of the Whitehead Institute—have begun to understand the dynamic nature and function of condensates. Dewpoint develops drugs that exploit this biology.</p>\n<p><b>About Dewpoint Therapeutics</b></p>\n<p>Dewpoint Therapeutics is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions have pathways that are regulated by condensates or arise from the dysfunction of condensates — including cancer, neurodegeneration, infectious disease, and metabolic disease. Dewpoint scientists work in Boston, Dresden, and Berlin to translate condensate biology into treatments for the toughest diseases. Learn more at dewpointx.com, and follow us on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> and LinkedIn.</p>\n<p><b>About Palantir Technologies Inc.</b></p>\n<p>Palantir Technologies Inc. builds and deploys operating systems for the modern enterprise. Additional information is available at https://www.palantir.com.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir and Dewpoint Therapeutics Announce Strategic Partnership</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir and Dewpoint Therapeutics Announce Strategic Partnership\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 20:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/palantir-dewpoint-therapeutics-announce-strategic-115900746.html><strong>Business Wire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DENVER & BOSTON, December 20, 2021--(BUSINESS WIRE)--Palantir Technologies Inc. (NYSE: PLTR), a leading builder of operating systems for the modern enterprise, and Dewpoint Therapeutics (\"Dewpoint\"), ...</p>\n\n<a href=\"https://finance.yahoo.com/news/palantir-dewpoint-therapeutics-announce-strategic-115900746.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4023":"应用软件","BK4543":"AI","BK4547":"WSB热门概念","PLTR":"Palantir Technologies Inc."},"source_url":"https://finance.yahoo.com/news/palantir-dewpoint-therapeutics-announce-strategic-115900746.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2192962184","content_text":"DENVER & BOSTON, December 20, 2021--(BUSINESS WIRE)--Palantir Technologies Inc. (NYSE: PLTR), a leading builder of operating systems for the modern enterprise, and Dewpoint Therapeutics (\"Dewpoint\"), the leading biomolecular condensates company, today announced a partnership for Palantir’s Foundry platform to help power Dewpoint’s efforts to discover treatments and cures for the most challenging diseases.\nPalantir Foundry will help to enable researchers at Dewpoint to further their understanding of condensates biology by analyzing lab data along with other data sources, including data from the published literature and databases, to identify new compounds and therapeutic approaches.\nDewpoint will also use Foundry as the primary platform for its centralized knowledge repository, helping it contextualize its experimental results and prioritize the most viable outcomes. This multi-year agreement marks one of Palantir’s most comprehensive partnerships with a biotechnology company.\nPalantir Foundry is designed to integrate disparate and siloed information sources to lead to data-driven analysis and decision making. It allows users to track lineage across systems, making it particularly suited for work in life sciences and the biotechnology sector, where data sources come from several unique and separate systems.\nAt Dewpoint, Foundry will be able to work seamlessly with the existing systems in its laboratories to provide researchers with a comprehensive foundation for exploration and analysis.\n\"We think Dewpoint is changing the way the world approaches drug design by exploring new frontiers of disease biology, requiring a game changing solution that goes beyond just cloud and infrastructure to drive their R&D and scale with their vision as they grow,\" said Lalarukh Haris Shaikh, Palantir’s Head of Biotech. \"We are proud to partner with Dewpoint and share their passion of working on one of the most exciting translational medicine approaches of our time.\"\nFoundry will help researchers make decisions around compound and target viability and streamline experiments and automate analysis by creating a digital twin of the research environment. One concrete example of Foundry’s use at Dewpoint Therapeutics is the expansion of the data foundation to include advanced genetic analysis for disease association and correlation with condensate content, empowering future discoveries.\n\"Key to our approach has been creating a seamless connection between our wet-lab and dry-lab capabilities, with machine learning and AI at the center. Foundry has provided us with a solid foundation for us to fully connect and operationalize our entire lab to enterprise and enable the discovery and development of new drugs,\" said Dewpoint CEO Ameet Nathwani.\nAbout Biomolecular Condensates\nBiomolecular condensates, formed through a process called phase separation, are membraneless droplets inside cells that facilitate molecular interactions and help cells perform vital functions. Condensates have been shown to play a critical role in key biological processes and in serious, intractable diseases across areas including neurodegeneration, cancer, inflammation, infectious disease, metabolic disease, and rare genetic disorders. The first condensates were observed more than 100 years ago. It is only in the last dozen years, though, that scientists—including Dewpoint founders Tony Hyman of the Max Planck Institute in Dresden and Rick Young of the Whitehead Institute—have begun to understand the dynamic nature and function of condensates. Dewpoint develops drugs that exploit this biology.\nAbout Dewpoint Therapeutics\nDewpoint Therapeutics is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions have pathways that are regulated by condensates or arise from the dysfunction of condensates — including cancer, neurodegeneration, infectious disease, and metabolic disease. Dewpoint scientists work in Boston, Dresden, and Berlin to translate condensate biology into treatments for the toughest diseases. Learn more at dewpointx.com, and follow us on Twitter and LinkedIn.\nAbout Palantir Technologies Inc.\nPalantir Technologies Inc. builds and deploys operating systems for the modern enterprise. Additional information is available at https://www.palantir.com.","news_type":1},"isVote":1,"tweetType":1,"viewCount":247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}